Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Ema    symbols : NVSEF    save search

Sandoz Marketing Authorization Applications for proposed biosimilar denosumab accepted by EMA
Published: 2023-05-25 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -1.37% H: 0.0% C: -0.89%
AMGN | News | $273.69 0.66% 0.65% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.0% C: -1.2%

biosimilar authorization ema
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
Published: 2022-07-25 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 3.12% H: 0.06% C: 0.06%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 0.31% C: 0.19%

fda biosimilar ema sclerosis multiple sclerosis
Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA
Published: 2022-06-17 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 0.52% C: -3.23%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.07% H: 0.0% C: 0.0%

biosimilar ema application
Fluorine-18 Market to Exceed US$ 3 Bn by 2030; Surge in Use of PET/CT Scan in Oncology Spurs Demand for FDGs, Notes Study by TMR
Published: 2022-01-06 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 0.82% C: 0.7%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 0.16% C: -0.45%
GE | News | $162.62 8.28% 0.22% 19M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.91% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M twitter stocktwits trandingview |
Health Technology
| | O: -2.81% H: 0.0% C: 0.0%
LNTH | $64.41 2.13% 2.08% 590K twitter stocktwits trandingview |
Health Technology
| | O: -1.42% H: 2.7% C: 2.11%

ema scan
Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA
Published: 2021-12-22 (Crawled : 07:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.55% H: 0.99% C: 0.92%

ema application authorization biosimilar
Female Infertility Drugs Market to Grow by USD 538.69 mn | AbbVie Inc. and Aurobindo Pharma Ltd. Among Key Vendors | Technavio
Published: 2021-12-14 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -3.62% H: 0.0% C: -0.56%
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.5% C: -0.43%
ABBV | News | $169.54 0.98% -0.91% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.51% H: 0.0% C: 0.0%

ema drug pharma
BD Selects "embecta" as Name of New Company for Planned Spinoff of Diabetes Care Business; Announces Remainder of Leadership Team
Published: 2021-12-06 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -4.23% H: 0.11% C: 0.11%
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 2.02% H: 0.04% C: -0.89%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.0% C: 0.0%
BSX | $68.99 1.43% 0.19% 9.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.0% C: 0.0%
BDX | $234.36 0.21% 0.0% 800K twitter stocktwits trandingview |
Health Technology
| | O: 0.68% H: 0.0% C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: 1.15% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.02% H: 0.0% C: 0.0%

ema diabetes
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: -0.89%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.28% C: 0.18%
INCY | $51.62 -0.58% -0.58% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: 2.41% H: 0.0% C: 0.0%

ema car-t platform
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.